1.Approved by the FDA in 2001, the patch is sold by prescription and releases ethinyl estradiol (a type of estrogen), and a progestin called norelgestromin via the skin into the bloodstream.
4.The relevant hormone determining results show: Prolactin (PRL), estradiol (E2) and progesterone (P) content in serum have regularly changed during reproductive and nonreproductive phase.
5.Methods:To detect the blood serum testosterone(T),pregnendione(P) and estradiol(E2)levels of the male patients with climacteric hypertension and the control group by radioimmunoassay.